FDA 483 - I.G. Raak - November 17, 2022

An FDA inspection of I.G. Raak in Jasper, MN, revealed two significant observations related to animal drug use. The firm offered a food-producing animal for interstate commerce with an unapproved drug residue (ciprofloxacin) in edible tissue. Additionally, the firm administered animal drugs contrary to label directions and without a valid veterinary/client/patient relationship, specifically regarding flunixin meglumine and penicillin.